Archives
-
Ro 3306: A Phase-Resolved CDK1 Assay Strategy
2026-09-28
Ro 3306 is a selective CDK1 inhibitor for dissecting mitotic entry, mTORC1 oscillation, and DNA repair. This guide develops a phase-resolved workflow that separates cell-state effects from mechanism.
-
Vasopressin Analogues: Mechanisms and Applications
2026-09-28
Glavaš and colleagues review how vasopressin structure and receptor pharmacology inform peptide analogues with distinct antidiuretic and vasoconstrictive profiles. The review connects established endocrine uses, including lypressin for diabetes insipidus, with emerging applications while underscoring the limits of peptide delivery and early antiviral evidence.
-
Firefly Luciferase mRNA for LNP Assay Design
2026-09-27
Use a modified luciferase reporter to separate mRNA delivery and translation performance from promoter-driven transcription. This workflow pairs practical cell-based optimization with evidence-informed choices for comparing bench-scale lipid nanoparticle mixing approaches.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-09-26
Zhang and colleagues show that loss of CDC42-dependent epithelial polarity shifts intestinal crypts toward transit-amplifying cell expansion through a YAP/TAZ–epiregulin–EGFR–mTOR signaling cascade. Genetic and inhibitor-based rescue experiments distinguish restoration of cell-population balance from restoration of epithelial polarity, providing a mechanistic framework for studying intestinal homeostasis.
-
Pregnenolone Carbonitrile: Beyond Hepatic PXR
2026-09-25
Pregnenolone Carbonitrile is widely used to probe rodent PXR signaling, especially in xenobiotic metabolism. New research connects PXR activation to hypothalamic vasopressin expression and urine concentration, broadening the questions translational researchers can ask while underscoring the need for tissue-specific and species-aware study design.
-
Tyrothricin: A Better Framework for Membrane Assays
2026-09-25
Tyrothricin is a peptide antibiotic mixture suited to studying antimicrobial activity through membrane-focused experiments. This article offers a distinct assay-design framework: separate membrane damage from growth inhibition, control for redox-related confounders, and interpret findings within the limits of the evidence.
-
Diphenyleneiodonium Chloride in ROS Assays
2026-09-24
Use DPI as a perturbation tool to test whether flavoprotein-linked ROS contributes to iron-associated plant defense—not as a pathway-specific readout. This workflow pairs dose-finding and time-resolved measurements with vehicle, viability, and bacterial-growth controls to help interpret redox effects in citrus canker research.
-
EZ Cap™ Cy5 EGFP mRNA: From Uptake to Function
2026-09-24
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) helps researchers distinguish cellular uptake of Cy5-labeled mRNA from downstream EGFP expression. This article connects dual-reporter assay design to targeted lipid nanoparticle research and explains what each fluorescence signal can—and cannot—show.
-
Palmitic acid: Practical Protocol and QC Guide
2026-09-23
Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a characterized fatty-acid input for lipid metabolism, insulin signaling, and inflammation studies. It is water-insoluble, so it is not suited to direct aqueous preparation; use a compatible solvent, matched vehicle controls, and freshly prepared solutions rather than long-term solution storage.
-
BEND Lipids for mRNA and CRISPR Delivery
2026-09-23
The reference study introduces branched endosomal disruptor (BEND) ionizable lipids that improve lipid nanoparticle delivery of both mRNA and CRISPR-Cas9 ribonucleoprotein complexes. Comparative hepatic and T-cell experiments associate terminal branching with stronger endosomal penetration, disruption, transfection, and gene-editing activity, while also showing why lipid architecture must be evaluated in a cargo- and cell-specific context.
-
mRNA Lipoplexes as an Intravenous Tumour Vaccine
2026-09-22
The 2024 reference study optimized PEGylated cationic mRNA lipoplexes prepared by modified ethanol injection and tested them as an intravenously administered tumour vaccine. Its lead formulation reduced erythrocyte agglutination and lung accumulation while preserving strong antibody and cytotoxic immune responses, with measurable suppression of E.G7-OVA tumour growth.
-
Resveratrol and the SIRT1–Mitochondria Axis
2026-09-22
Resveratrol is more than a broad antioxidant in neurodegeneration research: evidence from prion-challenged N2a cells connects SIRT1 activation to PGC-1α–TFAM-mediated mitochondrial biogenesis and apoptosis control. This article translates that mechanism into a practical strategy for designing more rigorous neuroprotection assays and interpreting translational boundaries.
-
Pseudo-UTP Workflow for Stable mRNA Synthesis
2026-09-21
Pseudo-UTP enables controlled pseudouridine incorporation for mRNA synthesis with pseudouridine modification, supporting RNA stability enhancement, translation, and immunogenicity studies. This practical guide pairs nucleotide substitution with UTR screening to improve mRNA vaccine development and gene therapy RNA modification workflows.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-09-21
The Hoechst 33342/PI Double Staining Kit supports fluorescence-based separation of normal, apoptotic-like, and membrane-compromised cell populations using nuclear morphology and PI uptake. It is intended for scientific research workflows, not diagnostic or medical use, and should be interpreted with appropriate controls because dye patterns alone do not establish a complete mechanism of cell death.
-
SAPC-LNP mRNA Vaccines and Immune Memory
2026-09-20
The reference study introduces SAPC-LNPs, which combine sialic-acid targeting with cleavable PEG to improve dendritic-cell delivery, endosomal escape, and the durability of mRNA cancer vaccination. Its central finding is that durable protection depends on strong immune memory against tumor antigens while limiting immune memory against the lipid nanoparticle carrier.